Alle Storys
Folgen
Keine Story von LifeWatch AG mehr verpassen.

LifeWatch AG

EANS-Adhoc: LifeWatch AG/ AETNA contracts with LifeWatch nationally for NiteWatch Home Sleep Testing

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
22.09.2010
Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss 
Exchange:  LIFE), the leading provider of wireless telemedicine, 
announced today  that  Aetna  now has a national contract with 
LifeWatch to provide access to the  NiteWatch  Home Sleep Test (HST) 
service for their members effective September 15, 2010.
A large percentage of patients with suspected Obstructive Sleep Apnea
(OSA)  are reluctant to go to a sleep lab to be tested.  Since  38  
million  Americans  are affected by OSA1, millions of patients remain
undiagnosed and at risk  for  more serious complications from OSA 
like stroke and heart disease. NiteWatch  HST  is clinically 
equivalent to sleep lab testing for diagnosing OSA and  is  conducted
in the privacy of the patient´s home making it a less  intimidating  
alternative for many patients and concerned loved ones.
LifeWatch serves physicians by  integrating  electronic  medical  
records  (EMR) with remote telemedicine services to support  more  
cost  effective  and  timely services while providing clinically 
relevant decisional  information.  NiteWatch HST now expands patient 
care options to all  physicians.  This  is  yet  another example of 
how LifeWatch is scaling and aggregating a variety  of  solutions  to
address growing healthcare needs and industry challenges.
"The addition of NiteWatch service to  the  Aetna  national  provider
agreement represents an important  step  in  our  goal  to  provide  
the  highest  quality diagnostic services at an economical delivery 
cost," said Brent  Cohen,  CEO  of LifeWatch. "Changing the way 
healthcare is delivered and serviced  is  essential to effecting 
change and allowing high quality clinically  superior  services  to 
be affordable and available to  all.  Working  with  progressive  
thinkers  like Aetna will allow LifeWatch to make a  contribution  by
making  affordable  home sleep testing services broadly available 
through all physicians."
About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am 
Rheinfall and listed  on  SIX  Swiss Exchange (LIFE), Switzerland, is
the leading healthcare technology and  solution company, specializing
in  advanced  telemedicine  systems  and  wireless  remote patient 
monitoring services. LifeWatch services cater  to  individuals,  
ranging from high-risk  and  chronically  ill  patients,  to  
consumers  of  health  and wellness  products.  LifeWatch  has  
subsidiaries  in  the  United  States,  the Netherlands, Japan, the 
United Kingdom, Switzerland and Israel. LifeWatch AG  is the parent 
company of  LifeWatch  Services  Inc.,  a  leading  US-based  cardiac
monitoring service provider. LifeWatch has also introduced  a  new  
program  for Home Sleep Testing of Obstructive Sleep Apnea (OSA)  
patients  under  the  brand name NiteWatch. For additional 
information, please visit www.lifewatch.com.
About Aetna Aetna  is  one  of  the  nation´s  leading  diversified  
health  care   benefits companies, serving  approximately  35.8  
million  people  with  information  and resources to help them make 
better informed decisions about their health  care.  Aetna  offers  a
broad  range  of  traditional  and  consumer-directed   health 
insurance products and related services, including  medical,  
pharmacy,  dental, behavioral health, group life  and  disability  
plans,  and  medical  management capabilities and  health  care  
management  services  for  Medicaid  plans.  Our customers include 
employer groups, individuals, college students, part-time  and hourly
workers, health plans, governmental  units,  government-sponsored  
plans, labor groups and expatriates.  For more information, see 
www.aetna.com.
Sign-up for customized E-mail alerts and documentation requests is 
available  at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking  statements.  All  
statements  other than statements of historical facts contained in 
this press  release,  including statements regarding  future  results
of  operations  and  financial  position, business strategy and plans
and objectives for future operations,  are  forward- looking 
statements. The words "believe," "may," "will," "estimate,"  
"continue," "anticipate,"  "intend,"  "expect"  and  similar  
expressions  are  intended  to identify forward-looking statements.  
LifeWatch  AG  has  based  these  forward- looking statements largely
on current expectations and projections about  future events  and  
financial  trends  that  it  believes  may  affect  the   financial 
condition, results of operations, business strategy, short term  and 
long  term business operations and objectives, and financial needs.  
These  forward-looking statements are subject to a number of risks, 
uncertainties and  assumptions.  In light of these risks, 
uncertainties and assumptions, the forward-looking  events and 
circumstances described may  not  occur  and  actual  results  could 
differ materially and adversely from those  anticipated  or  implied 
in  the  forward- looking statements. All  forward-looking  
statements  are  based  only  on  data available to LifeWatch AG at 
the time  of  the  issue  of  this  press  release. LifeWatch AG does
not undertake any obligation  to  update  any  forward-looking 
statements contained in this press release  as  a  result  of  new  
information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN  THE  UNITED  STATES  OF  
AMERICA  AND SHOULD NOT BE DISTRIBUTED TO  UNITED  STATES  PERSONS  
OR  PUBLICATIONS  WITH  A GENERAL  CIRCULATION  IN  THE  UNITED  
STATES.   THIS  PRESS  RELEASE  DOES  NOT CONSTITUTE AN OFFER OF 
SECURITIES OF LIFEWATCH AG OR  ANY  OF  ITS  SUBSIDIARIES FOR SALE IN
THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE  ANY 
SECURITIES OF LIFEWATCH  AG  OR  ITS  SUBSIDIARIES  IN  THE  UNITED  
STATES.  IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND  ITS  
SUBSIDIARIES  HAVE  NOT  BEEN REGISTERED UNDER THE UNITED STATES 
SECURITIES LAWS AND MAY NOT BE OFFERED,  SOLD OR DELIVERED WITHIN THE
UNITED STATES OR TO  U.S.  PERSONS  ABSENT  REGISTRATION UNDER OR AN 
APPLICABLE EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  OF  THE 
UNITED STATES SECURITIES LAWS.  ANY PUBLIC OFFERING OF SECURITIES TO 
BE MADE  IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS  
THAT  MAY  BE  OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS 
APPLICABLE, AND WILL CONTAIN  DETAILED INFORMATION ABOUT THE ISSUER 
AND ITS MANAGEMENT AS WELL AS FINANCIAL  STATEMENTS OF THE ISSUER.
end of announcement                               euro adhoc

Further inquiry note:

For further information please contact:
Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | E-mail wkim@lifewatch.com

Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard

Weitere Storys: LifeWatch AG
Weitere Storys: LifeWatch AG